J.P. Lindenmayer

1.5k total citations
17 papers, 1.1k citations indexed

About

J.P. Lindenmayer is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, J.P. Lindenmayer has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 6 papers in Clinical Psychology and 4 papers in Pharmacology. Recurrent topics in J.P. Lindenmayer's work include Schizophrenia research and treatment (13 papers), Treatment of Major Depression (4 papers) and Obsessive-Compulsive Spectrum Disorders (3 papers). J.P. Lindenmayer is often cited by papers focused on Schizophrenia research and treatment (13 papers), Treatment of Major Depression (4 papers) and Obsessive-Compulsive Spectrum Disorders (3 papers). J.P. Lindenmayer collaborates with scholars based in United States, Canada and Australia. J.P. Lindenmayer's co-authors include Leonard White, Philip D. Harvey, Lewis A. Opler, Larry Alphs, Anzalee Khan, Laurent Boyer, Jimmy Lee, Christoph U. Correll, Pál Czobor and Ravi Anand and has published in prestigious journals such as Schizophrenia Bulletin, Schizophrenia Research and JAMA Psychiatry.

In The Last Decade

J.P. Lindenmayer

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Lindenmayer United States 11 820 319 224 189 176 17 1.1k
Berna Binnur Akdede Türkiye 17 788 1.0× 318 1.0× 196 0.9× 178 0.9× 219 1.2× 58 1.1k
Stephen M. Erhart United States 8 802 1.0× 232 0.7× 184 0.8× 191 1.0× 172 1.0× 8 1.0k
Scott W Woods United States 11 536 0.7× 224 0.7× 214 1.0× 241 1.3× 249 1.4× 17 964
Luchezar Hranov Israel 9 1.1k 1.3× 319 1.0× 132 0.6× 275 1.5× 200 1.1× 17 1.3k
Evangelos Papanastasiou United Kingdom 8 564 0.7× 155 0.5× 167 0.7× 142 0.8× 131 0.7× 11 826
Douglas S. Lehrer United States 14 688 0.8× 329 1.0× 201 0.9× 151 0.8× 335 1.9× 24 1.3k
Haranath Parepally United States 16 986 1.2× 320 1.0× 133 0.6× 204 1.1× 141 0.8× 24 1.2k
Irvin Epstein Canada 12 796 1.0× 317 1.0× 189 0.8× 385 2.0× 110 0.6× 18 983
Marta Rapado‐Castro Spain 21 857 1.0× 340 1.1× 98 0.4× 126 0.7× 286 1.6× 53 1.3k
Athanasios Karavatos Greece 22 619 0.8× 261 0.8× 220 1.0× 134 0.7× 360 2.0× 46 1.2k

Countries citing papers authored by J.P. Lindenmayer

Since Specialization
Citations

This map shows the geographic impact of J.P. Lindenmayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Lindenmayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Lindenmayer more than expected).

Fields of papers citing papers by J.P. Lindenmayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Lindenmayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Lindenmayer. The network helps show where J.P. Lindenmayer may publish in the future.

Co-authorship network of co-authors of J.P. Lindenmayer

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Lindenmayer. A scholar is included among the top collaborators of J.P. Lindenmayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Lindenmayer. J.P. Lindenmayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hagi, Katsuhiko, Dwight Dickinson, J.P. Lindenmayer, et al.. (2021). Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia. JAMA Psychiatry. 78(5). 510–510. 108 indexed citations
2.
3.
Meltzer, Herbert Y., et al.. (2014). A six month randomized controlled trial of long acting injectable risperidone 50 and 100 mg in treatment resistant schizophrenia. Schizophrenia Research. 154(1-3). 14–22. 26 indexed citations
4.
Khan, Anzalee, J.P. Lindenmayer, Mark Opler, et al.. (2014). The evolution of illness phases in schizophrenia: A non-parametric item response analysis of the Positive and Negative Syndrome Scale. Schizophrenia Research Cognition. 1(2). 53–89. 4 indexed citations
5.
Fu, Dong‐Jing, Larry Alphs, J.P. Lindenmayer, et al.. (2014). P.3.d.023 Paliperidone palmitate long-acting injectable delays psychotic and mood symptom relapse in schizoaffective disorder. European Neuropsychopharmacology. 24. S534–S535. 1 indexed citations
6.
Lindenmayer, J.P., et al.. (2012). Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophrenia Research. 142(1-3). 171–176. 84 indexed citations
7.
Lindenmayer, J.P., et al.. (2011). Ziprasidone's Effect on Metabolic Markers in Patients with Diabetes and Chronic Schizophrenia. Clinical Schizophrenia & Related Psychoses. 5(4). 185–192. 4 indexed citations
8.
Lindenmayer, J.P., et al.. (2009). Schizophrenia with Impulsive and Aggressive Behaviors. Psychiatric Clinics of North America. 32(4). 885–902. 5 indexed citations
9.
Lindenmayer, J.P., et al.. (2009). N-Desmethylclozapine. Clinical Neuropharmacology. 32(3). 154–157. 42 indexed citations
10.
Lindenmayer, J.P., Saurabh Kaushik, Craig A. Branch, et al.. (2008). Does computerized cognitive remediation change brain activation patterns in schizophrenia: fMRI pilot data. European Psychiatry. 23. S127–S128. 3 indexed citations
11.
Altamura, A. Carlo, Emanuela Mundo, Roberta Bassetti, et al.. (2006). Transcultural differences in suicide attempters: Analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder. Schizophrenia Research. 89(1-3). 140–146. 22 indexed citations
12.
Hoptman, Matthew J., Jan Volavka, Guido Gerig, et al.. (2006). Aggression and Quantitative MRI Measures of Caudate in Patients With Chronic Schizophrenia or Schizoaffective Disorder. Journal of Neuropsychiatry. 18(4). 509–515. 38 indexed citations
13.
14.
Lindenmayer, J.P., et al.. (2002). The InterSePT scale for suicidal thinking reliability and validity. Schizophrenia Research. 63(1-2). 161–170. 78 indexed citations
15.
Kane, John M., et al.. (2001). Long-acting risperidone microspheres for treatment of patients with schizophrenia. European Neuropsychopharmacology. 11. S292–S292. 4 indexed citations
16.
White, Leonard, Philip D. Harvey, Lewis A. Opler, & J.P. Lindenmayer. (1997). Empirical Assessment of the Factorial Structure of Clinical Symptoms in Schizophrenia. Psychopathology. 30(5). 263–274. 306 indexed citations
17.
Lindenmayer, J.P.. (1995). Five factor model of schizophrenia: replication across samples. Schizophrenia Research. 14(3). 229–234. 284 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berna Binnur Akdede Breakdown of academic impact, for papers by Stephen M. Erhart Breakdown of academic impact, for papers by Scott W Woods Breakdown of academic impact, for papers by Luchezar Hranov Breakdown of academic impact, for papers by Evangelos Papanastasiou Breakdown of academic impact, for papers by Douglas S. Lehrer Breakdown of academic impact, for papers by Haranath Parepally Breakdown of academic impact, for papers by Irvin Epstein Breakdown of academic impact, for papers by Marta Rapado‐Castro Breakdown of academic impact, for papers by Athanasios Karavatos
Rankless by CCL
2026